Stock listing

NASDAQ:MDCX Medicus Pharma Ltd. Stock

Home listing (NASDAQ) of Medicus Pharma Ltd.

Follow Medicus Pharma Ltd. into a list and get an email when it puts out news.

Share price · NASDAQ:MDCX

$1.14 USD -0.25 (-18.3%)

Close on Nov 20, 2026

Past year -98.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.06 – $1.23 USDNov 20, 2026
Volume
86,765 sharesNov 20, 2026
Market cap
$2.18M USDAt the close on Nov 20, 2026 · price × 1.92M shares outstanding
52-week range
$1.06 – $114.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$88,363 USDMedian day 7,266 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Medicus Pharma Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MDCX · Home$1.135 USD-0.255 (-18.3%)86,765$1.13$1.23$1.06$1.39Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MDCX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.135-0.255-18.3%$1.13$1.23$1.0686,765
$1.39-0.13-8.6%$1.52$1.52$1.3554,902
$1.52-0.17-10.1%$1.69$1.815$1.5064,186
$1.69-0.26-13.3%$1.98$2.017$1.6577,935
$1.95+0.23+13.4%$1.75$2.00$1.7047,990
$1.72+0.08+4.9%$1.68$1.74$1.6537,673
$1.64-0.19-10.4%$1.80$1.853$1.6353,476
$1.83-0.055-2.9%$1.92$2.10$1.7287,456
$1.885+0.015+0.8%$1.87$2.165$1.78961,905
$1.87+0.04+2.2%$1.88$2.00$1.8129,304
$1.83-0.05-2.7%$1.85$1.906$1.7042,584
$1.88-0.15-7.4%$2.12$2.156$1.71233,987
$2.03+0.10+5.2%$1.95$2.12$1.9025,977
$1.93+0.05+2.7%$1.86$1.982$1.7830,806
$1.88-0.27-12.6%$2.17$2.18$1.8286,634
$2.15-0.33-13.3%$2.48$2.48$2.125123,204
$2.48+0.03+1.2%$2.50$2.689$2.4519,908
$2.45-0.06-2.4%$2.50$2.623$2.4043,239
$2.51+0.01+0.4%$2.53$2.63$2.4138,542
$2.50-0.12-4.6%$2.60$2.61$2.5083,983
$2.62-0.06-2.2%$2.70$2.80$2.5744,155
$2.68-0.04-1.5%$2.71$2.907$2.6530,707
$2.72+0.065+2.4%$2.60$2.93$2.5692,115
$2.655-0.595-18.3%$3.12$3.233$2.5599,356
$3.25-0.18-5.2%$3.61$3.61$3.2528,223
$3.43+0.31+9.9%$3.09$3.653$3.00203,135
$3.12-0.16-4.9%$3.08$3.25$2.92169,943
$3.28-0.30-8.4%$3.54$3.675$3.1466,106
$3.58-1.025-22.3%$4.20$4.69$3.58125,038
$4.605-0.49-9.6%$4.325$4.74$4.206,933
$5.095-2.915-36.4%$5.75$5.775$4.7055,824
$8.01+0.05+0.6%$8.00$8.15$7.9951,915
$7.96-0.39-4.7%$8.27$8.47$7.90422
$8.35+0.30+3.7%$8.275$8.545$7.755685
$8.05+0.20+2.5%$7.80$8.19$7.75416
$7.85-0.20-2.5%$7.91$8.095$7.665453
$8.05+0.22+2.8%$7.875$8.42$7.75726
$7.83+0.225+3.0%$7.55$7.945$7.50563
$7.605-0.015-0.2%$7.545$7.775$7.35609
$7.62-0.32-4.0%$8.01$8.02$7.505840
$7.94-0.03-0.4%$8.25$8.25$7.7251,098
$7.97-0.23-2.8%$8.00$8.15$7.755600
$8.20-0.35-4.1%$8.40$8.50$7.851,471
$8.55+0.035+0.4%$8.50$8.795$8.3151,178
$8.515-0.015-0.2%$8.46$8.775$7.901,206
$8.53+0.72+9.2%$7.90$9.35$7.907,811
$7.81+0.205+2.7%$7.505$7.99$7.5051,324
$7.605-0.36-4.5%$7.55$7.78$7.3751,267
$7.965-0.165-2.0%$8.34$8.35$7.202,187
$8.13+0.06+0.7%$7.84$8.13$7.6751,435
$8.07-0.45-5.3%$8.59$8.62$7.857,266
$8.52+0.02+0.2%$8.18$8.59$8.181,975
$8.50-0.10-1.2%$8.60$10.13$8.0559,358
$8.60+0.075+0.9%$8.11$9.15$8.006,347
$8.525-4.47-34.4%$10.25$10.33$7.5638,664
$13.00+0.435+3.5%$12.58$13.00$12.58142
$12.56-0.53-4.0%$13.00$13.08$12.50192
$13.09+0.205+1.6%$12.75$13.28$12.63167
$12.89-0.505-3.8%$13.31$13.56$12.77236
$13.39-0.035-0.3%$13.48$13.75$13.10281
$13.43+0.375+2.9%$13.54$13.54$12.77294
$13.05+0.18+1.4%$12.68$13.75$12.68344
$12.87-0.72-5.3%$13.50$13.75$12.75330
$13.59-0.02-0.1%$13.32$13.75$13.26341
$13.61+0.385+2.9%$13.50$14.00$13.04961

Splits

2 splits since 2024 · NASDAQ:MDCX · every price before a split is adjusted for it

DayRatioWhat
1-for-50Consolidation
1-for-2Consolidation
Ticker
NASDAQ:MDCX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Medicus Pharma (NASDAQ:MDCX) Q3 2026 Earnings Call

    Mon, Nov 09, 2026 · 11:30 AM ET

    Watch Transcript

Latest news

All Medicus Pharma Ltd. news

Financings

  • Private placement of common shares

    Nov 16, 2026

    Closed: US$1.25M raised · US$1.72 a share

    Buyers: Dr. Raza Bokhari (through RBx Capital LP) (436,046 common shares; $750,000)

    Insiders: Certain directors and senior officers purchased an aggregate of 616,272 common shares, including $750,000 from the Executive Chairman and CEO

    Use of proceeds: Working capital for operating and development priorities including CD228V, and possibly debt repayment

    Closed Nov 16, 2026

  • Registered direct offering of common shares and pre-funded warrants

    Nov 16, 2026

    Closed: US$3M raised · US$1.72 a share · Maxim Group LLC

    Dealers: Maxim Group LLC

    Use of proceeds: Working capital for operating and development priorities including CD228V, and possibly debt repayment

    Closed Nov 16, 2026

  • At-the-market programme of common shares

    Nov 16, 2026

    Tranche closed: US$350,000 raised

    Tranche closed Nov 16, 2026

  • Warrant exercise of series A and Series B Warrants exercised for common shares

    Dec 5, 2025

    Announced: about US$5.1M · US$1.92 a share · ½ warrant at US$2 for 66 months · Maxim Group LLC

    Dealers: Maxim Group LLC

    Announced Dec 5, 2025

  • Non-dilutive debenture

    Sep 18, 2025

    Closed: US$8M raised

    Buyers: YA II PL, Ltd. (Yorkville) (purchased the $8.0 million principal amount debenture)

    Use of proceeds: Accelerate development of Teverelix for acute urinary retention and high CV risk prostate cancer

    Closed Sep 18, 2025

  • Common shares

    Feb 11, 2025

    Announced: raise

    Buyers: YA II PN, LTD (option to sell up to US$15,000,000 of common shares over 36 months)

    Announced Feb 11, 2025

Read by 6ix AI from the company's releases

Decks

Medicus Pharma Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
55 in the last 12 months · 89 in all · newest Nov 19, 2026 · oldest 2024
Calls
1 call with a replay · 1 with a transcript · latest Nov 9, 2026
Decks
1 deck · latest Nov 9, 2026

Where Medicus Pharma Ltd. is listed

ListingExchangeCountryCurrency
NASDAQ:MDCX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:MDCXBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Medicus Pharma Ltd.